Supplemental Tables for "No evidence for metabolic risk and glucagon-like peptide-1 (GLP-1) receptor agonist use in folliculitis decalvans: a retrospective cohort study using TriNetX"

Published: 6 January 2026| Version 3 | DOI: 10.17632/8hbs8sbdhk.3
Contributor:
Alexa Podolsky

Description

Supplemental Tables for "No evidence for metabolic risk and glucagon-like peptide-1 (GLP-1) receptor agonist use in folliculitis decalvans: a retrospective cohort study using TriNetX"

Files

Categories

Dermatology, Metabolic Disorder, Alopecia, Hair Loss, Glucagon-Like Peptide-1 Receptor Agonist

Licence